AMPH Q1 2017 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$57M-4.5% YoY

Gross Profit

$23M40.3% margin

Operating Income

$1M2.5% margin

Net Income

$893,0001.6% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

-10.8%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$436M

Total Liabilities

$110M

Stockholders' Equity

$326M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$59M	-4.5%
Gross Profit	$23M	$25M	-8.3%
Operating Income	$1M	$4M	-65.5%
Net Income	$893,000	$2M	-64.1%

Revenue Segments

Active Pharmaceutical Ingredient Segment

$736,000100%

Geographic Segments

U

$56M100%